New York Palace Hotel
New York, New York
February 21-22, 2018.

PRESENTATION DATE AND TIME:

Presentation Information
Date: Thursday, February 22, 2018
Time: 8:30 AM EST

Webcast Link:
https://www.veracast.com/webcasts/rbc/healthcare2018/82215356404.cfm

The webcast will be archived for 30 days following the presentation.

Tyme Inc. announced that efficacy data from its lead therapy SM-88 in patients with advanced or metastatic pancreatic cancer will be presented in a poster session at the 2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, to be held Jan. 18-20, 2018, at the Moscone West Building in San Francisco, California.

Details on the poster are as follows:

Title: SM-88 therapy in patients with advanced or metastatic pancreatic cancer
Abstract Number: 457
Poster Session: Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Poster Board Number: M4
Date / Time: Friday, Jan. 19, 11:30 a.m. – 1 p.m., and 5:30 p.m. – 6:30 p.m. PST
Location: Moscone West Building, Level 1
Presenter: Giuseppe Del Priore, M.D., Chief Medical Officer, Tyme

Additional information on the meeting can be found on the ASCO Gastrointestinal Cancers Symposium website: https://gicasym.org/.

Tyme Technologies Inc. today announced that management will present at the
36th Annual J.P. Morgan Healthcare Conference, to be held January 8-11, 2018, in San Francisco, California.

PRESENTATION DATE AND TIME:

Presentation Information
Date: Thursday, January 11, 2018
Time: 8:30 AM – 8:55 AM

Q&A Session
Date: Thursday, January 11, 2018
Time: 9:00 AM – 9:25 AM

A live webcast of the presentation will be available in the “Investors” section of the Tyme website, www.tymeinc.com/investors.

Webcast Link:
https://jpmorgan.metameetings.net/events/healthcare18/sessions/14283-tyme/webcast

The webcast will be archived on the Company’s website for 30 days following the presentation.